# Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer

> **NCT07154563** · — · RECRUITING · sponsor: **Yunnan Cancer Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer Metastatic
- Sentinel Lymph Node
- Sentinel Lymph Node Biopsy (SLNB)
- Metastasis

## Interventions

- **DIAGNOSTIC_TEST:** NIR-II probe (i.e ICG-CK) incubation solution

## Key facts

- **NCT ID:** NCT07154563
- **Lead sponsor:** Yunnan Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07154563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07154563, "Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07154563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*